Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
RSC Medicinal Chemistry|August 6, 2021
Tumor pyruvate kinase M2 modulators: a comprehensive account of activators and inhibitors as anticancer agentsBhagyashri Rathod, Shivam Chak, Sagarkumar Patel, et al.
Drug Development Research|October 18, 2018
Drug development and bioanalytical method validation for a novel anticancer molecule, 4-(dimethylamino)-2-(p-tolylamino) thiazole-5-carbonitrileNripendra Madhab Biswas, Amit Shard, Sagarkumar Patel, et al.
Organic & Biomolecular Chemistry|October 6, 2020
Potassium tert-butoxide mediated C-C, C-N, C-O and C-S bond forming reactionsJayashree Madasu, Shital Shinde, Rudradip Das, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|April 10, 2019
Design, computational studies, synthesis and biological evaluation of thiazole-based molecules as anticancer agentsAnuradha, Sagarkumar Patel, Rajkumar Patle, et al.
The Journal of Organic Chemistry|December 15, 2016
Intramolecular Acylation of Unactivated Pyridines or Arenes via Multiple C-H Functionalizations: Synthesis of All Four Azafluorenones and FluorenonesJoydev K Laha, Krupal P Jethava, Sagarkumar Patel, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|December 31, 2021
Novel imidazopyrimidines-based molecules induce tetramerization of tumor pyruvate kinase M2 and exhibit potent antiproliferative profileSagarkumar Patel, Christoph Globisch, Priyanka Pulugu, et al.
Bioorganic & Medicinal Chemistry Letters|January 10, 2022
Boronic acid derivative activates pyruvate kinase M2 indispensable for redox metabolism in oral cancer cellsMohd Rihan, Lakshmi Vineela Nalla, Anil Dharavath, et al.
Gene|February 21, 2022
Objective assessment of adrenocortical carcinoma driver genes and their correlation with tumor pyruvate kinase M2Rudradip Das, Moumita Ghosh Chowdhury, Sonal Raundal, et al.
Pageof 2